Cathie Wood started to build up the position in Syros Pharmaceuticals in Q4 2016 and continued to invest until Q3 2020. Since then they sold 1.12 Million shares. The investor completely sold their stake between Q4 2020 and Q2 2021.
Avg closing price
Price range
Sold -771 Thousand shares
Q2 2021
Avg closing price
$5.92
Price range
$5.01
-
$7.48
Sold 14.7% shares (-133 Thousand shares)
Q1 2021
Avg closing price
$10.39
Price range
$7.19
-
$14.95
Sold 19.4% shares (-217 Thousand shares)
Q4 2020
Avg closing price
$9.12
Price range
$6.66
-
$14.66
Increased shares by 31.7% (+270 Thousand shares)
Q3 2020
Avg closing price
$11.36
Price range
$8.69
-
$14.47
Increased shares by 44.3% (+261 Thousand shares)
Q2 2020
Avg closing price
$8.98
Price range
$5.21
-
$11.03
Increased shares by 16.2% (+82.2 Thousand shares)
Q1 2020
Avg closing price
$6.78
Price range
$4.46
-
$9.20
Increased shares by 69.7% (+209 Thousand shares)
Q4 2019
Avg closing price
$6.07
Price range
$4.52
-
$10.10
Increased shares by 21.6% (+53.2 Thousand shares)
Q1 2019
Avg closing price
$6.96
Price range
$5.51
-
$9.59
Increased shares by 10.7% (+23.9 Thousand shares)
Q4 2018
Avg closing price
$7.60
Price range
$5.56
-
$11.34
Increased shares by 23.5% (+42.2 Thousand shares)
Q3 2018
Avg closing price
$11.60
Price range
$9.74
-
$12.92
Increased shares by 19.6% (+29.5 Thousand shares)
Q2 2018
Avg closing price
$12.38
Price range
$10.16
-
$13.65
Increased shares by 80.3% (+67 Thousand shares)
Q1 2018
Avg closing price
$10.93
Price range
$9.47
-
$12.98
Increased shares by 519.8% (+70 Thousand shares)
Q4 2017
Avg closing price
$13.43
Price range
$8.45
-
$17.48
Increased shares by 661.0% (+11.7 Thousand shares)
Q3 2017